282 related articles for article (PubMed ID: 21310926)
1. KDM2b/JHDM1b, an H3K36me2-specific demethylase, is required for initiation and maintenance of acute myeloid leukemia.
He J; Nguyen AT; Zhang Y
Blood; 2011 Apr; 117(14):3869-80. PubMed ID: 21310926
[TBL] [Abstract][Full Text] [Related]
2. The H3K36 demethylase Jhdm1b/Kdm2b regulates cell proliferation and senescence through p15(Ink4b).
He J; Kallin EM; Tsukada Y; Zhang Y
Nat Struct Mol Biol; 2008 Nov; 15(11):1169-75. PubMed ID: 18836456
[TBL] [Abstract][Full Text] [Related]
3. JmjC-domain containing histone demethylase 1B-mediated p15(Ink4b) suppression promotes the proliferation of leukemic progenitor cells through modulation of cell cycle progression in acute myeloid leukemia.
Nakamura S; Tan L; Nagata Y; Takemura T; Asahina A; Yokota D; Yagyu T; Shibata K; Fujisawa S; Ohnishi K
Mol Carcinog; 2013 Jan; 52(1):57-69. PubMed ID: 22086844
[TBL] [Abstract][Full Text] [Related]
4. Histone demethylase KDM2B regulates lineage commitment in normal and malignant hematopoiesis.
Andricovich J; Kai Y; Peng W; Foudi A; Tzatsos A
J Clin Invest; 2016 Mar; 126(3):905-20. PubMed ID: 26808549
[TBL] [Abstract][Full Text] [Related]
5. Lysine-specific demethylase 2B (KDM2B)-let-7-enhancer of zester homolog 2 (EZH2) pathway regulates cell cycle progression and senescence in primary cells.
Tzatsos A; Paskaleva P; Lymperi S; Contino G; Stoykova S; Chen Z; Wong KK; Bardeesy N
J Biol Chem; 2011 Sep; 286(38):33061-9. PubMed ID: 21757686
[TBL] [Abstract][Full Text] [Related]
6. Depletion of histone demethylase KDM2A inhibited cell proliferation of stem cells from apical papilla by de-repression of p15INK4B and p27Kip1.
Gao R; Dong R; Du J; Ma P; Wang S; Fan Z
Mol Cell Biochem; 2013 Jul; 379(1-2):115-22. PubMed ID: 23559091
[TBL] [Abstract][Full Text] [Related]
7. KDM2B is a histone H3K79 demethylase and induces transcriptional repression via sirtuin-1-mediated chromatin silencing.
Kang JY; Kim JY; Kim KB; Park JW; Cho H; Hahm JY; Chae YC; Kim D; Kook H; Rhee S; Ha NC; Seo SB
FASEB J; 2018 Oct; 32(10):5737-5750. PubMed ID: 29763382
[TBL] [Abstract][Full Text] [Related]
8. Fbxl10 overexpression in murine hematopoietic stem cells induces leukemia involving metabolic activation and upregulation of Nsg2.
Ueda T; Nagamachi A; Takubo K; Yamasaki N; Matsui H; Kanai A; Nakata Y; Ikeda K; Konuma T; Oda H; Wolff L; Honda Z; Wu X; Helin K; Iwama A; Suda T; Inaba T; Honda H
Blood; 2015 May; 125(22):3437-46. PubMed ID: 25872778
[TBL] [Abstract][Full Text] [Related]
9. Histone demethylase KDM2B promotes triple negative breast cancer proliferation by suppressing p15INK4B, p16INK4A, and p57KIP2 transcription.
Zheng Q; Fan H; Meng Z; Yuan L; Liu C; Peng Y; Zhao W; Wang L; Li J; Feng J
Acta Biochim Biophys Sin (Shanghai); 2018 Sep; 50(9):897-904. PubMed ID: 30060056
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic up-regulation of ribosome biogenesis and more aggressive phenotype triggered by the lack of the histone demethylase JHDM1B in mammary epithelial cells.
Galbiati A; Penzo M; Bacalini MG; Onofrillo C; Guerrieri AN; Garagnani P; Franceschi C; Treré D; Montanaro L
Oncotarget; 2017 Jun; 8(23):37091-37103. PubMed ID: 28415746
[TBL] [Abstract][Full Text] [Related]
11. Lysine demethylase 2B regulates angiogenesis via Jumonji C dependent suppression of angiogenic transcription factors.
Sasaki Y; Higashijima Y; Suehiro JI; Sugasawa T; Oguri-Nakamura E; Fukuhara S; Nagai N; Hirakawa Y; Wada Y; Nangaku M; Kanki Y
Biochem Biophys Res Commun; 2022 May; 605():16-23. PubMed ID: 35306360
[TBL] [Abstract][Full Text] [Related]
12. A systematic study of the cellular metabolic regulation of Jhdm1b in tumor cells.
Yu X; Wang J; Wu J; Shi Y
Mol Biosyst; 2015 Jul; 11(7):1867-75. PubMed ID: 25877602
[TBL] [Abstract][Full Text] [Related]
13. Targeting glioma stem-like cell survival and chemoresistance through inhibition of lysine-specific histone demethylase KDM2B.
Staberg M; Rasmussen RD; Michaelsen SR; Pedersen H; Jensen KE; Villingshøj M; Skjoth-Rasmussen J; Brennum J; Vitting-Seerup K; Poulsen HS; Hamerlik P
Mol Oncol; 2018 Mar; 12(3):406-420. PubMed ID: 29360266
[TBL] [Abstract][Full Text] [Related]
14. The H3K4me3 histone demethylase Fbxl10 is a regulator of chemokine expression, cellular morphology, and the metabolome of fibroblasts.
Janzer A; Stamm K; Becker A; Zimmer A; Buettner R; Kirfel J
J Biol Chem; 2012 Sep; 287(37):30984-92. PubMed ID: 22825849
[TBL] [Abstract][Full Text] [Related]
15. ASH1L Links Histone H3 Lysine 36 Dimethylation to MLL Leukemia.
Zhu L; Li Q; Wong SH; Huang M; Klein BJ; Shen J; Ikenouye L; Onishi M; Schneidawind D; Buechele C; Hansen L; Duque-Afonso J; Zhu F; Martin GM; Gozani O; Majeti R; Kutateladze TG; Cleary ML
Cancer Discov; 2016 Jul; 6(7):770-83. PubMed ID: 27154821
[TBL] [Abstract][Full Text] [Related]
16. KDM2B in polycomb repressive complex 1.1 functions as a tumor suppressor in the initiation of T-cell leukemogenesis.
Isshiki Y; Nakajima-Takagi Y; Oshima M; Aoyama K; Rizk M; Kurosawa S; Saraya A; Kondo T; Sakaida E; Nakaseko C; Yokote K; Koseki H; Iwama A
Blood Adv; 2019 Sep; 3(17):2537-2549. PubMed ID: 31471323
[TBL] [Abstract][Full Text] [Related]
17. Identification of Structural Elements of the Lysine Specific Demethylase 2B CxxC Domain Associated with Replicative Senescence Bypass in Primary Mouse Cells.
Deiktakis EE; Abrams M; Tsapara A; Stournaras C; Tsatsanis C; Tsichlis PN; Kampranis SC
Protein J; 2020 Jun; 39(3):232-239. PubMed ID: 32270414
[TBL] [Abstract][Full Text] [Related]
18. Kdm2b promotes induced pluripotent stem cell generation by facilitating gene activation early in reprogramming.
Liang G; He J; Zhang Y
Nat Cell Biol; 2012 Apr; 14(5):457-66. PubMed ID: 22522173
[TBL] [Abstract][Full Text] [Related]
19. The histone demethylase KDM2B regulates human primordial germ cell-like cells specification.
Yuan W; Yao Z; Veerapandian V; Yang X; Wang X; Chen D; Ma L; Li C; Zheng Y; Luo F; Zhao XY
Int J Biol Sci; 2021; 17(2):527-538. PubMed ID: 33613110
[TBL] [Abstract][Full Text] [Related]
20. KDM2B promotes pancreatic cancer via Polycomb-dependent and -independent transcriptional programs.
Tzatsos A; Paskaleva P; Ferrari F; Deshpande V; Stoykova S; Contino G; Wong KK; Lan F; Trojer P; Park PJ; Bardeesy N
J Clin Invest; 2013 Feb; 123(2):727-39. PubMed ID: 23321669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
